SEMM - Systematic Assessment of Menière's Disease: Prospective Observational Study

Recruiting

• Conditions: H81.0; Ménière disease

• Registration Number: DRKS00027830
• Lead Sponsor: Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, LMU Klinikum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-03-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 999

Inclusion Criteria

All patients with Menière's Disease who are treated in the neurotology outpatient clinic at the LMU Clinic and had given informed consent to participation in the study.

Exclusion Criteria

Vestibular migraines, other vestibular diseases.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Observational Study<br>Primary and secondary endpoints will be assessed at the respective treatment intervals 3, 6, 9, or 12 months.<br>Primary endpoints:<br>- Classification for the Menière categories: probable, definitive Menière’s Disease, Menière characteristica<br>- Treatment result and complications of the different treatment options<br>- Course of disease<br>- Change in quality of life<br><br>Secondary endpoints:<br>- Estimation of prognosis<br>- Contentment of patients<br>- Doctor patient relation

Secondary Outcome Measures

Name	Time	Method
Treatment scheme